119 related articles for article (PubMed ID: 20583078)
1. Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?
Abraham JM; Thompson JA
Liver Transpl; 2010 Jul; 16(7):809-11. PubMed ID: 20583078
[No Abstract] [Full Text] [Related]
2. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
3. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
[TBL] [Abstract][Full Text] [Related]
4. [Advances in immunossuppression in liver transplantation].
Olivera-Martínez MA
Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine-based immunotherapy for pediatric liver transplantation in Hong Kong.
Chan KL; Saing H; Fan ST; Wei WI; Ng IO; Tsoi NS
Transplant Proc; 1996 Jun; 28(3):1302-3. PubMed ID: 8658669
[No Abstract] [Full Text] [Related]
6. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
[No Abstract] [Full Text] [Related]
7. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
[No Abstract] [Full Text] [Related]
8. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252
[No Abstract] [Full Text] [Related]
9. Future directions in immunosuppression.
Beckebaum S; Cicinnati VR; Broelsch CE
Transplant Proc; 2004 Mar; 36(2 Suppl):574S-576S. PubMed ID: 15041408
[TBL] [Abstract][Full Text] [Related]
10. Tumors after transplantation: are there associated factors?
Jacobs U; Paar D; Buszello H; Klehr HU
Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
[No Abstract] [Full Text] [Related]
11. Immunosuppression in liver transplantation: monitoring, dose adjustment, reduction, and withdrawal.
Wall WJ; Ghent CN
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):3-10. PubMed ID: 9346595
[No Abstract] [Full Text] [Related]
12. The immunosuppressive pipeline: meeting unmet needs in liver transplantation.
Selzner N; Grant DR; Shalev I; Levy GA
Liver Transpl; 2010 Dec; 16(12):1359-72. PubMed ID: 21117245
[TBL] [Abstract][Full Text] [Related]
13. Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.
Mor E; Schwersenz A; Sheiner PA; Emre S; Schwartz ME; Miller CM
Transplantation; 1994 Apr; 57(7):1130-2. PubMed ID: 7513098
[No Abstract] [Full Text] [Related]
14. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine.
Furukawa H; Todo S
Transplant Proc; 2004 Mar; 36(2 Suppl):274S-284S. PubMed ID: 15041353
[TBL] [Abstract][Full Text] [Related]
15. Changing perspectives on the role of corticosteroids after liver transplantation.
Lucey MR
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
[No Abstract] [Full Text] [Related]
16. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
17. Neoral/cyclosporine-based immunosuppression.
Levy GA
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S37-47. PubMed ID: 10431016
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in liver transplantation.
Post DJ; Douglas DD; Mulligan DC
Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
[No Abstract] [Full Text] [Related]
19. Long-term immunosuppression after liver transplantation: are steroids necessary?
Padbury RT; Gunson BK; Dousset B; Hubscher SG; Mayer AD; Buckels JA; Neuberger JM; Elias E; McMaster P
Transpl Int; 1992; 5 Suppl 1():S470-2. PubMed ID: 14621849
[TBL] [Abstract][Full Text] [Related]
20. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns.
Saliba F; Ichaï P; Azoulay D; Habbouchi H; Antonini T; Sebagh M; Adam R; Castaing D; Samuel D
Ther Apher Dial; 2010 Feb; 14(1):116-23. PubMed ID: 20438529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
